Tylvalosin is a macrolide antibiotic. Macrolide are metabolites or derivatives of metabolites of soil organisms obtained by fermentation. They interfere with protein synthesis by reversibly binding to the 50S ribosome subunit. They are generally considered bacteriostatic.
Tylvalosin has activity against the following mycoplasma species found in chickens: Mycoplasma gallisepticum.
Macrolide (including Tylvalosin) have been shown to have effects on the innate immune
system, which may augment the direct effects of the antibiotic on the pathogen and aid the clinical situation.
Each one gram contains:………………………………………………715 mg Tylvalosin tartrate.
Eq. to 625 mg Tylvalosin base.
Treatment and prevention of respiratory disease associated with Mycoplasma gallisepticum in chickens.
Dosage & Route of administration:
Route of administration: orally via drinking water.
For whole product:
400 gm Royaltvlosin / 10.000 kg of body weight. For 3 days.
40 gm Royaltvlosin /1000 kg body weight. For 3 days.
The product may be mixed directly into the drinking water system or first mixed as a stock solution into a smaller amount of water, which is then added into the drinking water system.
Contra – Indication:
Not authorized for use in laying birds producing eggs for human consumption. Do not use within 14 days of onset of the laying.
No signs of intolerance have been observed in chickens at up to 150 mg Tylvalosin per kg bodyweight per day for 5 days.
Meat and offal: 2 days.
Stored at temperature not exceed 30 C˚.
White plastic (HDPE) container closed with white plastic (HDPE) cap outer label of 100, 250, 500 gm& 1kg.